Proteomic Approaches to Identify Novel Therapeutics and Nutraceuticals from Filamentous Fungi

A mushroom derived ‘carbohydrate‐fraction’ reinstates host‐immunity and protects from Leishmania donovani infection

“…Hence, interests have been renewed in developing cost-efficient therapeutics with low toxicity and high immune potentials. Mushrooms belong to the group of basidiomycetes (fungi) and their metabolites have recently gained attention due to their broad spectrum of biological activities, ranging from antimicrobial to immunomodulation, 8 making them a promising source for various new treatment approaches. Low toxicity broadens the scope for exploring edible mushrooms as new anti-leishmanial leads.…”